John M. Gansner
Impact in
- Immunology top 5%
- Complement system in diseases
- Cell Biology top 5%
- Zebrafish Biomedical Research Applications
Papers in
-
- Kidney Stones and Urolithiasis Treatments 13
-
- Zebrafish Biomedical Research Applications 8
- Co-authors
- Jonathan D. Gitlin (6 shared papers)Richard Max Kaufman (5 shared papers)Robert S.J. Makar (2 shared papers)Iván O. Rosas (2 shared papers)Marisa B. Marques (1 shared paper)Stephen W. Waldo (1 shared paper)Ang Li (1 shared paper)Lynne Uhl (1 shared paper)
- Journals
- Blood (4 papers)Transfusion (3 papers)Developmental Dynamics (3 papers)American Journal of Kidney Diseases (2 papers)Journal of Hepatology (2 papers)
- Partner nations
- United StatesNetherlandsIsrael
In The Last Decade
John M. Gansner
37 papers receiving 1.7k citations
John M. Gansner's Hit Papers
Peers
Comparison fields: 5 of 89
- Immunology 354
- Cell Biology 173
- Pulmonary and Respiratory Medicine 335
- Hematology 138
- Clinical Biochemistry 44
Countries citing papers authored by John M. Gansner
This map shows the geographic impact of John M. Gansner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Gansner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Gansner more than expected).
Fields of papers citing papers by John M. Gansner
This network shows the impact of papers produced by John M. Gansner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Gansner. The network helps show where John M. Gansner may publish in the future.
Co-authors
The 25 scholars most cited alongside John M. Gansner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1 Hit paper breakdown → | 2021 | 403 |
| 2 | 2017 | 389 | |
| 3 | 2021 | 137 | |
| 4 | 2007 | 76 | |
| 5 | 2014 | 69 | |
| 6 | 2018 | 67 | |
| 7 | 2022 | 66 | |
| 8 | 2006 | 57 | |
| 9 | 2008 | 45 | |
| 10 | 2022 | 39 | |
| 11 | 2008 | 36 | |
| 12 | 2021 | 36 | |
| 13 | 2016 | 33 | |
| 14 | 2013 | 32 | |
| 15 | 2016 | 27 | |
| 16 | 2021 | 27 | |
| 17 | 2012 | 25 | |
| 18 | 2011 | 23 | |
| 19 | 2020 | 19 | |
| 20 | 2018 | 15 |
About John M. Gansner
John M. Gansner is a scholar working on Pulmonary and Respiratory Medicine, Cell Biology, Management of Technology and Innovation, Genetics and Hematology, having authored 38 papers that have together received 1.7k indexed citations. Recurring topics across this work include Kidney Stones and Urolithiasis Treatments (13 papers), Zebrafish Biomedical Research Applications (8 papers), Blood disorders and treatments (5 papers), Developmental Biology and Gene Regulation (5 papers), Blood donation and transfusion practices (4 papers), Liver Disease Diagnosis and Treatment (2 papers), Telomeres, Telomerase, and Senescence (2 papers) and Hematopoietic Stem Cell Transplantation (2 papers). The work is most often cited by research in Immunology (354 citations), Cell Biology (173 citations), Pulmonary and Respiratory Medicine (335 citations), Hematology (138 citations) and Clinical Biochemistry (44 citations). John M. Gansner has collaborated with scholars based in United States, Netherlands and Israel. Frequent co-authors include Jonathan D. Gitlin, Richard Max Kaufman, Robert S.J. Makar, Iván O. Rosas, Marisa B. Marques, Stephen W. Waldo, Ang Li, Lynne Uhl, Srinivas Raghavan Viswanathan and Ayad Hamdan. Their work appears in journals such as Blood, Transfusion, Developmental Dynamics, American Journal of Kidney Diseases and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.